We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to transmit to future generations a world that can ensure access to quality health care for all. Corporate growth at Servier is driven by our continuous pursuit of innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric diseases, cancer and diabetes. We are a leading force in cardiology—number 2 in Europe, number 6 worldwide—and we aim to become a recognized player in oncology. Together we share the passion of entrepreneurship and we are committed to therapeutic progress to serve patient needs. With 100 million of patients treated each day worldwide by our medicinal products, we are keenly aware of our responsibilities to patients, doctors and health care professionals. They are the motivating force behind our daily drive for innovation as a provider of therapeutic progress. -- To report a suspected adverse event with a Servier drug, please visit www.servier.pt/contacte-nos/#reportar-um-efeito-indesejavel